Anoma Cancer Collective emerges as more than a nonprofit framework. It represents a drive to restore healthcare control to physicians, patients, families, and the local areas they serve.

/PRNewswire/ - We hold that community cancer care merits strong advocacy. Physicians must retain autonomy to thrive, and families should access treatment nearby from teams familiar with their backgrounds and committed to their journeys.

This conviction drives the creation of Anoma Cancer Collective (ACC). ACC goes beyond reacting to payment reductions, coverage disputes, facility dynamics, billing updates, or mergers. It forms a deliberate shift from a system that often views doctors as suppliers and patients as numbers, toward renewed focus on the doctor-patient bond.

The initiative developed through careful planning, resolve, and effort. Over 18 months, Radiation Business Solutions (RBS) committed more than $10 million in effort, assets, legal preparation, financial design, review, and operational knowledge to build a framework capable of supporting physicians and families over time.

ACC starts with eight cancer centers in five states and offers robust local providers a route to maintain community direction while securing capital, facilities, operational aid, and enduring strategic tools. It targets physicians and groups performing well now but seeking enhanced stability ahead.

"This reaches the heart of healthcare, extending beyond oncology to doctors in various fields seeking to safeguard the doctor-patient connection," said Dan Moore, CEO of Radiation Business Solutions. "Local providers should avoid choosing between autonomy and security. When physician challenges align with suitable economic models and motivations, patients, families, doctors, staff, and communities gain. This guided the development of ACC."

Investors have endorsed this approach on two occasions. Several institutional backers participated again in nonprofit funding with RBS following the success of the initial structure, Aurora Integrated Oncology Foundation (AIOF), in Alaska. Their continued involvement signals trust in the approach and RBS execution across healthcare, finance, operations, and community efforts at scale.

The effort carries personal weight. Numerous RBS staff members have encountered cancer among relatives and grasp the anxiety of diagnosis, caregiver strain, and value of accessible, reliable, personal care. This background powers a purpose exceeding billing, funding, oversight, or individual deals.

ACC shifts the model from transaction-focused services to collaborative partnerships that bolster physicians, safeguard access, and aid communities. Via its nonprofit setup, centers obtain tax-exempt funding, shared resources, bond financing, operational guidance, and avenues for charitable support, service growth, and sustained reinvestment.

RBS received backing from institutional investors Baird Advisors and Capital Research and Management Company, prior partners in AIOF financing, while adding First Eagle Investment Management, LLC as a new participant. Loop Capital Markets again acted as underwriter, extending its prior role.

"Many local oncology groups seek not rescue but a framework for forward planning, confident investment, and market competitiveness," said Sally Eggleston, COO of Radiation Business Solutions. "We designed ACC for centers aiming to keep independence while obtaining support to expand and serve communities effectively."

RBS engaged directly with civic officials in ACC communities. Moore consulted county and city commissioners plus council members tied to the centers, who voiced backing for sustained, local cancer services.

"I joined Anoma Cancer Collective as it tackles clinical and operational issues facing community oncology leaders," said Hejal Patel, MD, Chief Medical Officer of ACC. "This approach enables centers to plan for growth and enhance existing strengths while delivering quality care independently."

ACC invites physicians, providers, community figures, donors, and aligned partners to support a robust future for local care. RBS investors have tasked the firm with expanding ACC by over 60 percent, beginning with more oncology locations and later assessing applications in other pressured specialties.

"Our goal is to develop RBS as a lasting enterprise that affects families well beyond any single deal. We are 22 years along, and this marks our moment for meaningful contribution. We appreciate this chance," Moore said. "ACC embodies that goal. It focuses on creating value for physicians, patients, and trusting communities." To date, RBS has issued over $300 million in bonds for radiation centers.

About Radiation Business Solutions

Radiation Business Solutions (RBS) operates as a national advisory and management firm aiding oncology providers with strategic, financial, operational, and oversight expertise. RBS collaborates with cancer centers nationwide to boost performance, address reimbursement issues, ease administrative loads, reinforce physician-led care, and provide quality patient services.

About Anoma Cancer Collective

Anoma Cancer Collective (ACC) functions as a nonprofit network of community oncology providers dedicated to sustaining local cancer access. It supplies capital, shared services, operational infrastructure, and strategic support to help centers stay independent amid healthcare shifts. ACC also enables local reinvestment, philanthropy, expanded services, and community effects.

SOURCE Radiation Business Solutions